The dopaminergic response in multiple system atrophy

Hughes, A J; Colosimo, C; Kleedorfer, B; Daniel, S E; Lees, A J
November 1992
Journal of Neurology, Neurosurgery & Psychiatry;Nov1992, Vol. 55 Issue 11, p1009
Academic Journal
journal article
No abstract available.


Related Articles

  • Movement disorders: from a new test to diagnose MSA to tic generation. Strupp, Michael // Journal of Neurology;Oct2006, Vol. 253 Issue 10, p1381 

    The article discusses various articles in the field of movement disorders published within the issue, including one on multiple system atrophy, and another on D2-receptor binding in hypoactive dopaminergic neurotransmission in restless legs syndrome.

  • MODERN APPROACHES TO DIAGNOSING EARLY PARKINSON'S DISEASE. Rosinskaya, A. V.; Datieva, V. K. // Pacific Medical Journal / Tihookeanskij Medicinskij Zurnal;2013, Vol. 51 Issue 3, p8 

    The paper reviews bibliography related to early diagnostics and differential di-agnostics of Parkinso's disease and discusses characteristics of tremor, non-motor disorders and other neurological symptoms and responses to dopaminergic medications prescribed to treat Parkinson's disease....

  • Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Booij, Jan; Tissingh, Gerrit; Winogrodzka, Ania; van Royen, Eric A. // European Journal of Nuclear Medicine;1999, Vol. 26 Issue 2, p171 

    Abstract. Parkinsonism is a feature of a number of neurodegenerative diseases, including Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. The results of post-mortem studies point to dysfunction of the dopaminergic neurotransmitter system in patients with...

  • The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy. Cochen De Cock, Valérie; Debs, Rachel; Oudiette, Delphine; Leu, Smaranda; Radji, Fatai; Tiberge, Michel; Yu, Huan; Bayard, Sophie; Roze, Emmanuel; Vidailhet, Marie; Dauvilliers, Yves; Rascol, Olivier; Arnulf, Isabelle // Brain: A Journal of Neurology;Mar2011, Vol. 134 Issue 3, p856 

    Multiple system atrophy is an atypical parkinsonism characterized by severe motor disabilities that are poorly levodopa responsive. Most patients develop rapid eye movement sleep behaviour disorder. Because parkinsonism is absent during rapid eye movement sleep behaviour disorder in patients...

  • Dopamine and Paraquat Enhance α-Synuclein-Induced Alterations in Membrane Conductance. Feng, Li; Maguire-Zeiss, Kathleen // Neurotoxicity Research;Nov2011, Vol. 20 Issue 4, p387 

    We have previously demonstrated that α-synuclein overexpression increases the membrane conductance of dopaminergic-like cells. Although α-synuclein is thought to play a central role in the pathogenesis of several neurodegenerative diseases including Parkinson's disease, multiple system...

  • P25α immunoreactivity in multiple system atrophy and Parkinson disease. Jellinger, Kurt A. // Acta Neuropathologica;Jul2006, Vol. 112 Issue 1, p112 

    A letter to the editor is presented in response to the article "P25α immunoreactivity in multiple system atrophy and Parkinson disease" by KG Baker in the May 11, 2006 issue.

  • Multiple system atrophy.  // Nursing Standard;2/6/2008, Vol. 22 Issue 22, p58 

    A quiz concerning the multiple system atrophy, an adult-onset disease, is presented.

  • Causes of death in multiple system atrophy. Papapetropoulos, Spiridon; Tuchman, Alexander; Laufer, Daniel; Papatsoris, Athanassios G.; Papapetropoulos, Nektarios; Mash, Deborah C. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2007, Vol. 78 Issue 3, p327 

    A letter to the editor is presented that discusses the causes of death in multiple system atrophy.

  • Amantadine-induced myoclonus in a patient with progressive supranuclear palsy. Yarnall, Alison Jane; Burn, David John // Age & Ageing;Sep2012, Vol. 41 Issue 5, p695 

    Progressive supranuclear palsy (PSP) is a tauopathy that generally results in a hypokinetic disorder. Treatment is largely symptomatic, with some small studies indicating a benefit with dopaminergic therapy. Myoclonus is a hyperkinetic disorder that can be seen as part of later stage Parkinson's...

  • Case 27-2004: Multiple-System Atrophy. Schatz, Irwin J. // New England Journal of Medicine;12/30/2004, Vol. 351 Issue 27, p2881 

    A letter to the editor is presented in response to the article "Case 27-2004: Multiple-System Atrophy," by Michael G. Schlossmacher and Claus Hamann in the August 26, 2004 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics